peoplePerson
Ge Li
aka 李革
Ge Li founded WuXi AppTec in Shanghai in 2000 and built the contract research and manufacturing network that much of the world's cancer pipeline now depends on.
Overview
A Columbia-trained chemist who created China's first major CRO, then WuXi Biologics and (with Juno) JW Therapeutics; WuXi's discovery chemistry, toxicology and manufacturing services sit behind a large share of Western and Chinese oncology programmes, which is why the company became the focus of the US BIOSECURE Act.
Role
Founder, Chairman and CEO, WuXi AppTec
Specialisms
Contract research and manufacturingMedicinal chemistryBiotech infrastructure
Profiles
Pages like this
not linked directly; found by shared links- ProductRelmacabtagene autoleucel
Shares WuXi AppTec, JW Therapeutics and the tag china.
- TrialRELIANCE
Shares JW Therapeutics and the tag china.